Bing Mei serves as Executive at SKYSTAR BIO-PHARMACEUTICAL CO, where they oversee executive responsibilities. Since joining the company, Bing Mei has executed 10 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 9, 2018 involved receiving (via award) 2,500 shares valued at $0.
Bing Mei currently holds 20,000 shares of SKYSTAR BIO-PHARMACEUTICAL CO (SKBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bing Mei has been a net neutral trader of SKBI stock. They have purchased $0 and sold $0 worth of shares.
Bing Mei's most recent insider trade was on Nov 9, 2018, when they sold 2,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 10, 2018 | KNDI | $0 | Award | 2,500 | $N/A | Discretionary |
| Jan 10, 2018 | KNDI | $0 | Award | 2,500 | $N/A | Discretionary |
| Oct 18, 2017 | KNDI | $0 | Award | 2,500 | $N/A | Discretionary |
| Aug 10, 2017 | KNDI | $0 | Award | 2,500 | $N/A | Discretionary |
| Apr 17, 2017 | KNDI | $0 | Award | 2,500 | $N/A | Discretionary |
| Feb 24, 2017 | KNDI | $0 | Award | 2,500 | $N/A | Discretionary |
| Mar 10, 2014 | SKBI | $0 | Award | 8,000 | $N/A | Discretionary |
| May 4, 2012 | SKBI | $46.4K | Award | 18,000 | $2.58 | Discretionary |